Barbra Sasu
Company: Allogene Therapeutics
Job title: Chief Scientific Officer
Seminars:
Evolution of Anti-Rejection Strategies for Allogeneic Cell Therapy 9:00 am
day: Day Two
Chair’s Opening Remarks 8:50 am
day: Day Two
Industry Leader’s Fireside Chat – Exploring the Past, Present & Future of Allogeneic Cell Therapies 8:15 am
An executive panel discussion from the industry leaders of the field to set the scene on the allogeneic cell therapy space. Ask your questions live to understand the expert’s thoughts on key topics including: The evolving shift in the cell therapy field from autologous to allogeneic Next generation and complex gene editing and the safety…Read more
day: Day One